期刊文献+

从哲学视角看:整合医学之“整合”意味着什么 被引量:4

From the Perspective of Philosophy: What does “Integration”Mean in Holistic Integrated Medicine?
下载PDF
导出
摘要 从哲学视角,围绕整合医学针对的时代背景、面临的现实问题和医学未来走向,重点就医学的本质理解和整合之"意味"给予详细分析,提出并阐述了"整合"意味着重塑"生命观""健康观"和"知识观"的观点。 From the perspective of philosophy, centering on the background, the realistic problems and the future trend of medicine, this paper analyzed the nature - understanding of medicine and the meaning of integration, and put forward that "integration" meantto reshape the view of life, health, and knowledge.
作者 赵美娟 ZHAO Meijuan(Chinese People's Liberation Army General Hospital, Beijing 100853, China)
出处 《中国医学伦理学》 2017年第6期670-675,共6页 Chinese Medical Ethics
关键词 生命观 健康观 知识观 整合医学 医学本质 :View of Life View of Health View of Knowledge Holistic Integrative Medicine Medical Essence
  • 相关文献

参考文献3

二级参考文献14

  • 1Wang C, Cao B, Liu QQ, et al. Oseltamivir compared withthe Chinese traditional therapy maxingshigan-yinqiaosanin the treatment of HjNj influenza: a randomized trialfj].Ann Intern Med, 2011, 155(4):217-225. 被引量:1
  • 2Li X, Zhang J, Huang J, et al. A multicenter, randomized,double-blind, parallel-group,placebo-controlled study ofthe effects of qili qiangxin capsules in patients with chronicheart failure[J]. J Am Coll Cardiol, 2013, 62(12):1065-1072. 被引量:1
  • 3Shang H, Zhang J, Yao C, et al. Qi-shen-yi-qi drippingpills for the secondary prevention of myocardial infarction:a randomised clinical trial[J]. Evid Based ComplementAltemat Med, 2013, 2013:738391. 被引量:1
  • 4Phase II multi-center study of T89 to treat chronic stableangina (T89 phase 2)[EB/OL].(2012-12-10) [2015-06].https://www.clinicaltrials.gov/ct2/show/NCT00797953?term=tasly&rank=6. 被引量:1
  • 5Phase III trial of Dantonic? (T89) Capsule to prevent and treatstable angina (CAESA) [EB/OL]. (2015-05-19) [2015-06].https://www.clinicaltrials.gov/ct2/show/NCT01659580?term=tasly&rank=3. 被引量:1
  • 6Assess the antifibrotic activity of Fuzheng Huayu in chronichepatitis C patients with hepatic fibrosis[EB/OL]. (2014-06-18)[2015-06]. https://www.clinicaltrials.gov/ct2/show/study/NCT00854087?cond=hepatic+fibrosis&spons=shanghai&rank=3. 被引量:1
  • 7Efficacy and safety study of lipid-lowering effects ofXueZhiKang (XZK) in patients with hyperlipidemia[EB/0L].(2014-07-22) [2015-06]. https://clinicaltrials.gov/ct2/show/NCT01327014?term=xuezhikang&rank=3. 被引量:1
  • 8Gruenwald J. The global herbs & botanicals market[EB/OL].[2015-06]. https://www.otciq.com/otciq/ajax/show FinancialReportById.pdf?id=27951. 被引量:1
  • 9张伯礼.系统生物学将推动中药复杂体系的深入研究[J].中国天然药物,2009,7(4):241-241. 被引量:7
  • 10吴国盛.技术释义[J].哲学动态,2010(4):86-89. 被引量:25

共引文献14

同被引文献49

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部